CPRT
Copart, Inc.
Copart, Inc. insider trading
Every time one of CPRT's executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
SEC Form 4 data, Q3 2024 to Q2 2026
CPRT insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 8 insiders traded CPRT on the open market: 0 purchases and 22 sales worth $90.1M, 4 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 12 sales ($18.9M), by 2 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$869.7K2 sales | |
| Q1 2026 | — | −$1M2 sales | |
| Q4 2025 | — | −$5M3 sales | |
| Q3 2025 | — | −$12M5 sales · 4 on a plan | |
| Q2 2025 | — | −$6M2 sales | |
| Q1 2025 | — | −$26.5M4 sales | |
| Q4 2024 | — | −$38.7M4 sales | |
| Q3 2024 | — | — |
- Largest sale
- −$16M of CPRT by Adair A Jayson (Executive Chairman · Director) on Nov 26, 2024.
Open-market transactions through Jun 30, 2026most recent first
Liaw Jeffrey
Chief Executive Officer
−$792K
Apr 15, 2026
23,870 sh · $33.18
Liaw Jeffrey
Chief Executive Officer
−$77.7K
Apr 15, 2026
2,343 sh · $33.17
Liaw Jeffrey
Chief Executive Officer
−$911.6K
Jan 15, 2026
22,693 sh · $40.17
Liaw Jeffrey
Chief Executive Officer
−$98.2K
Jan 15, 2026
2,444 sh · $40.17
Tryforos Thomas N
Director
−$3.9M
Nov 25, 2025
100,000 sh · $39.07
Liaw Jeffrey
Chief Executive Officer
−$989.2K
Oct 15, 2025
22,086 sh · $44.79
Liaw Jeffrey
Chief Executive Officer
−$98.4K
Oct 15, 2025
2,197 sh · $44.80
Tryforos Thomas N
Director
−$10.9M
Sep 15, 2025
228,840 sh · $47.54
Liaw Jeffrey10b5-1
Chief Executive Officer · Director
−$847.6K
Jul 15, 2025
18,288 sh · $46.35
Liaw Jeffrey10b5-1
Chief Executive Officer · Director
−$169.4K
Jul 15, 2025
3,616 sh · $46.84
Liaw Jeffrey10b5-1
Chief Executive Officer · Director
−$87.3K
Jul 15, 2025
1,884 sh · $46.35
Liaw Jeffrey10b5-1
Chief Executive Officer · Director
−$14.1K
Jul 15, 2025
300 sh · $46.90
Cohan Steven D
Director
−$5.7M
Apr 14, 2025
94,997 sh · $60.01
Cohan Steven D
Director
−$300.2K
Apr 11, 2025
5,003 sh · $60.01
Meeks James E
Director
−$5.4M
Mar 19, 2025
100,000 sh · $54.00
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Apr 15, 2026 | Liaw JeffreyChief Executive Officer | 23,870 | $33.18 | −$792K |
| Apr 15, 2026 | Liaw JeffreyChief Executive Officer | 2,343 | $33.17 | −$77.7K |
| Jan 15, 2026 | Liaw JeffreyChief Executive Officer | 22,693 | $40.17 | −$911.6K |
| Jan 15, 2026 | Liaw JeffreyChief Executive Officer | 2,444 | $40.17 | −$98.2K |
| Nov 25, 2025 | Tryforos Thomas NDirector | 100,000 | $39.07 | −$3.9M |
| Oct 15, 2025 | Liaw JeffreyChief Executive Officer | 22,086 | $44.79 | −$989.2K |
| Oct 15, 2025 | Liaw JeffreyChief Executive Officer | 2,197 | $44.80 | −$98.4K |
| Sep 15, 2025 | Tryforos Thomas NDirector | 228,840 | $47.54 | −$10.9M |
| Jul 15, 2025 | Liaw Jeffrey10b5-1Chief Executive Officer · Director | 18,288 | $46.35 | −$847.6K |
| Jul 15, 2025 | Liaw Jeffrey10b5-1Chief Executive Officer · Director | 3,616 | $46.84 | −$169.4K |
| Jul 15, 2025 | Liaw Jeffrey10b5-1Chief Executive Officer · Director | 1,884 | $46.35 | −$87.3K |
| Jul 15, 2025 | Liaw Jeffrey10b5-1Chief Executive Officer · Director | 300 | $46.90 | −$14.1K |
| Apr 14, 2025 | Cohan Steven DDirector | 94,997 | $60.01 | −$5.7M |
| Apr 11, 2025 | Cohan Steven DDirector | 5,003 | $60.01 | −$300.2K |
| Mar 19, 2025 | Meeks James EDirector | 100,000 | $54.00 | −$5.4M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
After insiders bought CPRT
What the stock actually did in the 90 days following each open-market purchase
Don't check CPRT — let it ping you
Get told the moment an insider moves on CPRT
Pro watches Copart, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add CPRT to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read CPRT insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Industrials tickers
Questions
- How much CPRT stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 8 Copart, Inc. insiders made no open-market purchases and 22 sales worth $90.1M. 4 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 12 sales ($18.9M). The largest sale was Adair A Jayson selling $16M on Nov 26, 2024.
- Where does CPRT insider trading data come from?
- From the Form 4 filings Copart, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.